The recently cloned gene (ATM) mutated in the human genetic disorder ataxia-telangiectasia (A-T) is involved in DNA damage response at dierent cell cycle checkpoints and also appears to have a wider role in signal transduction. Antibodies prepared against peptides from the predicted protein sequence detected a * 350 kDa protein corresponding to the open reading frame, which was absent in 13/23 A-T homozygotes. Subcellular fractionation, immunoelectronmicroscopy and immunouorescence showed that the ATM protein is present in the nucleus and cytoplasmic vesicles. This distribution did not change after irradiation. We also provide evidence that ATM protein binds to p53 and this association is defective in A-T cells compatible with the defective p53 response in these cells. These results provide further support for a role for the ATM protein as a sensor of DNA damage and in a more general role in cell signalling, compatible with the broader phenotype of the syndrome.
Introduction
The human genetic disorder ataxia-telangiectasia (A-T) is characterized by a progressive ataxia, immunodeficiency, neurological abnormalities, hypersensitivity to ionising radiation and predisposition to cancer (Sedgwick and Boder, 1991; Harnden, 1994; Shiloh, 1995; Meyn, 1995; Lavin and Shiloh, 1997) . The locus for A-T was mapped to chromosome 11q 22 ± 23 (Gatti et al., 1988) and the responsible gene (ataxiatelangiectasia mutated, ATM) was recently cloned using a positional cloning approach (Savitsky et al., 1995a) . ATM spans approximately 150 kb of genomic DNA and is composed of 66 exons. The major ATM mRNA of 13 kb contains a predicted open reading frame of 9.168 kb (Savitsky et al., 1995b; Uziel et al., 1996) . Targeted disruption of the ATM gene in mice produces a phenotype similar to the human disease (Barlow et al., 1996; .
It is not yet known what activity the ATM gene product possesses, but the homology of this gene to the phosphatidylinositol 3-kinase (PI3-kinase) gene family supports a role for ATM in intracellular signalling . The protein homologues of ATM include the TOR1 and TOR2 proteins of yeast (Kunz et al., 1993) and their mammalian counterparts RAFT1 and FRAP (Brown et al., 1994) , all of which are targets for the immunosuppressive drug rapamycin (Sabatini et al., 1994) . However, the ATM protein does not appear to be a direct target for rapamycin (Beamish et al., 1996a) . The ATM protein is more closely related to a second group of proteins, TEL1p and MEC1p from S. cerevisiae, (Morrow et al., 1995; Paulovich and Hartwell, 1995) , Rad3p from S. pombe (Al-Khodairy et al., 1994; Jimenez et al., 1992) , MEl-41 from Drosophila melanogaster (Hari et al., 1995) and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) from mammalian cells (Hartley et al., 1995) through the PI3-kinase domain and also through adjacent regions (Jackson, 1995; Lavin et al., 1995; Zakian, 1995) . All of these proteins are involved in maintaining the integrity of DNA and/or cell cycle control in response to DNA damage. Anomalies in cell cycle control after ionising radiation damage have been extensively described in A-T (Scott and ZampettiBosseler, 1982; Imray and Kidson, 1983; Nagasawa and Little, 1983; Ford et al., 1984) . These include failure to arrest at either the G 1 /S or G 2 /M checkpoints (Rudolph et al., 1989; Beamish and Lavin, 1994) as well as radioresistant DNA synthesis (Houldsworth and Lavin, 1980; Painter and Young, 1980) . A reduced and/or delayed response in the induction of p53 after exposure of A-T cells to ionising radiation can account for the defective G 1 /S checkpoint (Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane 1993; Canman et al., 1994; Khanna et al., 1995) . More recently it has been demonstrated that the ATM gene product is involved at multiple cell cycle checkpoints (Beamish et al., 1996b) .
In order to investigate the role of the ATM protein we have raised antibodies against dierent regions of the protein to compare mutated and normal froms of the protein, and to determine its subcellular localisation, and possible function.
Results

Detection of ATM protein
Antibodies were prepared in rabbits against peptides from the N-terminus (ATM-1BA), the interior of the molecule (ATM-2BA) and C-terminus (ATM-3BA) as well as against a 51 kDa recombinant fusion protein (ATM-4BA) from the 3' end of the ORF (amino acids 2323 ± 2740) excluding the PI3-kinase domain. The Cterminal peptide was also chosen from a region outside the PI3-kinase domain to minimise cross-reaction with homologous proteins. High titre sera were obtained for all four antibodies as determined by ELISA; ATM-1BA, 1: 204,800; ATM-2BA, 1: 12,800; ATM-3BA, 1: 614,400 and ATM-4BA 1: 51,200.
ATM-3BA antibody detected a protein of approximately 350 kDa in size in freshly isolated lymphocytes and lymphoblastoid cells. Twelve A-T and three control lymphoblastoid cell samples appear in Figure  1a , and eight freshly isolated lymphocyte samples appear in Figure 1b . It is evident that the *350 kDa band is absent in ®ve of the A-T lines. Anity-puri®ed antibodies and crude antiserum gave the same result. Pre-immune serum failed to detect this protein (data not shown). The *350 kDa protein corresponds well to the open reading frame of 9.168 kb (3056 amino acids) predicted from ATM cDNA (Savitsky et al., 1995b) . A total of 23 A-T lines were examined and 13/ 23 exhibited loss of the ATM protein. Table 1 shows the results for 16 of these lines for which mutations have been determined. Of nine cell lines where no ATM protein was detectable (Table 1) , four cell lines, AT5ABR, AT3LA and AT4LA (siblings) and AT13ABR, had mutations in both alleles predicted to give rise to truncated proteins. In the other ®ve cell lines a mutation giving rise to a truncated protein was detected in one allele and presumably this is also the case in the second allele (mutation not yet detected). In addition, in four other cell lines where no protein was detectable, we have not yet determined the site of mutation (results not shown). The *350 kDa protein was detected in 10/23 A-T lines and seven of these are shown in Table 1 .
As expected, near full-length protein was detected in the two aected siblings AT1ABR and AT2ABR, and in AT27RMO which are homozygous for an in-frame deletion of 9 nucleotides (codons 2546 ± 2548) ( Table  1) . The *350 kDa band was also detected in cell lines where mutations in one allele were expected to give rise to a truncated protein (AT8ABR, AT9ABR and GM1524; Figure 1a ). These data suggest that the mutation in the second allele (not yet determined) gives rise to an in-frame deletion/insertion or a missense mutation. Cross reacting bands were observed with antibodies in some cases and the appearance of some of these bands correlated with the presence of the ATM band. The signi®cance of this is not clear at this stage. The other three antibodies were also capable of detecting the ATM protein by immunoblotting ( Figure  2 ). Screening with these antibodies con®rmed the absence of protein in the same A-T cell lines used with ATM-3BA antibody. The results for ATM-1BA (N-terminal peptide) appear in Figure 2a . The ATM-2BA antibody (internal peptide) was less sensitive for Western blotting, but detected the same protein in AT44LA (Figure 2b ). The speci®city of these antibodies was demonstrated using competition experiments, ATM-3BA ( Figure 2e , and f) and ATM-4BA (Figure 2c and d) . In the case of ATM-4BA the reduction was signi®cant but not complete, as the competing protein was only present in a 15-fold excess as compared to 1000-fold competing peptide for ATM3BA.
Localisation of ATM protein to both the nucleus and microsomes
Evidence is accumulating that the product of the ATM gene is not only involved in sensing DNA damage in the nucleus, but may also play a more general role in cell cycle control and signal transduction (Savitsky et al., 1995a; O'Connor and Scott-Linthicum, 1980; Kondo et al., 1993; Lavin et al., 1994) . In order to address this question we determined the cellular localisation of the ATM protein. Cells were subfractionated into cytoplasmic, microsomal and nuclear fractions, and ATM protein assayed by Western Figure 3a show that the ATM protein is present both in the nucleus and in the microsomal fraction of control cells. A similar distribution was observed in nuclear and microsomal fractions in AT1ABR cells. Quantitation of the amount of protein in the dierent compartments demonstrated that approximately 20% of the protein was in the microsomes and 80% in the nucleus (averaged over several experiments). ATM protein was not detected in the post-microsomal cytoplasm of controls (100 000 g supernatant) ( Figure  3a upper panel) but some protein was detected in the cytoplasm of AT1ABR (Figure 3a upper panel). Antibody to the nuclear protein DNA-PKcs was used to con®rm that fractionation was representative of the dierent sub-cellular compartments (Figure 3a and b, lower panels). In addition, greater than 75% of lactate dehydrogenase activity, a cytosolic enzyme, was present in the cytoplasmic fraction (results not shown).
To con®rm the subcellular localisation determined by Western blotting, we used ultrathin cryosectioning and immunogold labelling to localise ATM proteins in microsomal preparations and in whole cells (primary ®broblasts and lymphoblastoid cells) from controls and A-T patients. All three anti-peptide antibodies were used in conjunction with immunogold-labelled secondary antibody. Extensive labelling was detected in microsomes prepared from control lymphoblastoid cells using ATM-3BA antibody (Figure 4a ). It is evident that the gold particles are localised to vesicles of varying sizes (60 ± 230 nm). A similar pattern was observed using ATM-2BA antibody (recognises interior of molecule) with the same microsomal preparation (Figure 4b ). The antibody directed against the Nterminus (ATM-1BA) also detected microsomal labelling (results not shown). Microsomes prepared from AT3LA, for which both alleles contain mutations predicted to give rise to truncated proteins, and for which no ATM protein could be detected by Western blotting, showed no labelling with ATM-3BA antibody as expected ( Figure 4c ). Studies were extended to include whole cell sections. All three anti-peptide antibodies detected a similar pattern of vesicular labelling in control ®broblasts (Figure 5a ± c) . This pattern of labelling was also seen in control lymphoblastoid cells using ATM-3BA antibody (Figure 5d ). Gold particles were concentrated in small vesicles throughout the cytoplasm as observed in ®broblasts. Again, as with the microsomal preparation, AT3LA cells did not show any labelling with ATM-3BA antibody ( Figure 5e ) or with ATM-1BA antibody (results not shown) which indicates that the truncated forms of the protein are unstable. Although ATM protein was readily detected in nuclear extracts by Western blotting, the amount of labelling seen in the nucleus of ultrathin sections for C3ABR was very low (results not shown). This might be explained by leakage of less tighly bound ATM protein from the nucleus or by a limitation in the technique using ultrathin sections.
In support of the biochemical and immunoelectronmicroscopic localisation of the ATM protein in ®broblasts we have also shown that ATM-1BA and ATM-4BA antibodies detect both nuclear and cytoplasmic labelling using immuno¯uorescence ( Figure 6 ). 
Eect of irradiation on ATM protein
Since ATM is distributed between two subcellular compartments and A-T cells are defective in their response to radiation (Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane, 1993; Canman et al., 1994; Khanna et al., 1995; Beamish et al., 1996b) it was possible that this protein either increased in amount or was altered in its distribution in response to radiation damage. Immunoblotting of nuclear and microsomal fractions isolated from cells exposed to radiation (5 and 10 Gy) showed no evidence of any change in the amount or distribution of the ATM protein in control or A-T cell lines (Figure 7a ). This was con®rmed by immuno¯uorescence which showed that there was no appreciable change in the ATM punctate staining in the cytoplasm or in the nucleus at various times after irradiation ( Figure 7b ).
Association of ATM protein with p53
It is now well established that the defect at the G 1 /S checkpoint in A-T is due to a defective response of p53 to ionising radiation (Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane, 1993) . Recent results have shown that the whole pathway operating through WAF1, cyclin-dependent kinase and the retinoblastoma protein fails to respond eciently to radiation in A-T cells (Canman et al., 1994; Khanna et al., 1995; Beamish et al., 1996b) . To understand the basis of the defective cell cycle G 1 arrest following radiation in A-T cells, we examined the possible association of p53 with ATM by immunoprecipitation. Lysates were prepared from control and A-T cells and immunoprecipitated with anti-p53 antibodies. Immunoblot analysis with Two of the A-T cell lines (AT3LA and L3) have mutations which result in homozygous truncation of the ATM protein while the third A-T line, AT1ABR, is characterized by a 9 bp in-frame deletion which produces a protein of size indistinguishable from wild type by immunoprecipitation (Figure 8 , bottom). We were able to detect a weak ATM band in p53 immunoprecipitates from AT1ABR upon longer exposure to X-ray ®lm (results not shown). Exposure of control cells to 6 Gy of ionising radiation did not appreciably increase the amount of ATM associated with p53 after 1 h, and radiation did not lead to an increased amount of ATM-p53 interaction in A-T cells.
In order to investigate whether the ATM-p53 interaction was direct rather than part of a complex we employed the yeast-two hybrid screen. A fragment of ATM cDNA including the PI3-kinase domain (encoding amino acid residues 1666 ± 3100) isolated from the partial cDNA (Savitsky et al., 1995a) units. These data demonstrate that ATM interacts directly with p53 in control cells and this association is defective in A-T.
Discussion
A protein of *350 kDa was detected in 20 control samples whereas in 13/23 A-T cases the protein was absent. The estimated size of this protein agrees with the 350.6 kDa size expected from the 3056 amino acids, predicted from the ATM ORF of 9.168 kb (Savitsky et al., 1995a) . The *350 kDa protein was detected in 43% (10/23) of the A-T cell lines, and of these, ®ve showed out of frame insertions/deletions in one allele as determined by the protein truncation test (Roest et al., 1993) . Of the remaining ®ve, AT1ABR, AT2ABR and AT27RMO have been shown to be homozygous for an in-frame deletion of nine nucleotides corresponding to codons 2546 ± 2548, upstream from the PI3-kinase domain. We have not been able to detect a truncation in another cell line AT7ABR, suggesting an in-frame deletion/insertion or missense mutations, and the other two have not been investigated. No protein was detected in 13 cell lines, two of which, AT3LA and AT4LA are siblings, with deletions in both alleles (homozygous) giving rise to truncated protein at codon 2497 (Savitsky et al., 1995a) . AT13ABR also had mutations giving rise to truncations in both alleles but the exact sequence change has not been determined. AT3ABR and AT4ABR have at least one truncation. In this study 57% of A-T cell lines had lost the ATM protein which compares very well with the number of frameshift truncations predicted from mutation analysis (Savitsky et al., 1995a; Telatar et al., 1996) . A-T is characterized at the cellular level by radiosensitivity, chromosome breakage and cell cycle anomalies (Shiloh, 1995; Meyn, 1995; Lavin and Shiloh, 1997) . The recent cloning and identi®cation of the ATM gene as a member of the PI3-kinase family suggests that it is involved in signal transduction pathways. Members of the ATM family have so far failed to show any intrinsic lipid kinase activity (Hunter, 1995) . However, the TOR proteins, DNA-PK, and PI-3 kinase display protein kinase activity (Hartley et al., 1995; Carpenter et al., 1993; Dhand et al., 1994; Brown et al., 1995) , suggesting that ATM may function as a protein kinase. We have provided evidence here by subcellular fractionation, immunoelectronmicroscopy and immuno¯uorescence, using antibodies directed against dierent regions of the molecule, that the ATM protein is present in the nucleus and in the microsomal fraction. The purity of these sub-fractions was also established using marker enzymes enriched in these compartments. The use of dierent antibodies and several methods to determine localisation, all of which are in agreement avoids the controversies that have arisen recently in the localisation of proteins such as BRCA1 Schnitt and Livingston, 1996) . Where nuclear ATM protein was detected by immunoelectronmicroscopy, it was associated with condensed chromatin and the nuclear membrane. While it is evident that ATM is a nuclear protein no obvious nuclear localisation signal is discernible in the primary sequence. The nuclear localisation of ATM is in keeping with a role for this protein in the detection of DNA damage and the transmission of this information via the p53 pathway to activate the G 1 /S checkpoint. As has been demonstrated previously, in response to ionising radiation damage, this pathway is defective in A-T (Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane, 1993; Canman et al., 1994; Khanna et al., 1995) .
More recently it has been demonstrated that ®broblasts from mice bearing targeted disruptions of the mouse ATM gene are defective in cell cycle G 1 arrest following radiation, correlating with a defective upregulation of p53 . The results obtained here demonstrating an interaction of ATM with p53 provide further evidence that the ATM gene is needed as a sensor to trigger the p53 response. In this context ATM may function by sensing DNA damage and signalling events that lead to stabilisation of p53. This stabilisation may be due to ATM directly phosphorylating p53, as suggested by the observation that DNA-PK, a relative of ATM, can phosphorylate p53 in vitro (Hartley et al., 1995) . However, it has recently been demonstrated that DNA-PKcs is not required to activate p53 in response to DNA damage since radiation-induced p53 response pathways are active in scid cells (Nacht et al., 1996) , suggesting that DNA-PKcs and ATM may function in distinct double-strand DNA damage response pathways. The failure to observe interaction between ATM and p53 in A-T cells together with the reduced or delayed induction of p53 in these cells post-irradiation suggests that there is some redundancy in the process dependent on the exact nature of the DNA damage. Our previous observation that u.v.-induced p53 in A-T cells is normal would support this .
Similar to DNA-PKcs, ATM may detect speci®c forms of DNA damage, possibly double strand breaks. It is notable that defects in DNA-PK are linked to de®ciency not only in DNA repair but also in V(D)J recombination (Finnie et al., 1996) . While no direct DNA repair defect appears to be responsible for the radiation hypersensitivity in A-T, abnormalities in DNA recombination are extensively described (Sedgwick and Boder, 1991; Harnden, 1994; Shiloh, 1995; Meyn, 1995; Lavin and Shiloh, 1997) . The ®nding that DNA-PKcs is present in an RNA polymerase II complex associated with DNA repair proteins (Maldonado et al., 1996) suggests that its function depends on the integrity of this complex. It is possible that ATM senses DNA damage in a similar fashion. Because of its homology to proteins involved in DNA-damage detection (Savitsky et al., 1995a; Lavin et al., 1995; Zakian, 1995; Jackson, 1995) and the wealth of data on radiosensitivity and cell cycle abnormalities in A-T it might be expected that ATM is essentially a DNA repair/processing protein. However, A-T is also characterised by immunodeficiency, neurological abnormalities, and developmental abnormalities in the thymus, liver and gonads, and there is evidence for a more general defect in signal transduction (O'Connor and Scot-Linthicum, 1980; Kondo et al., 1993; Lavin et al., 1994) . We have provided important new evidence to show that the ATM protein is localised to vesicular structures in the cytoplasm by subcellular localisation and immunogold labelling. We demonstrated this with antibodies to three dierent regions of the protein in both ®broblasts and lymphoblastoid cells. In one A-T cell line, AT3LA, where no protein was detected by Western blotting, it was evident that no immunogold labelling was detected with any of the antibodies employed in this study. Since the ATM-1BA antibody, which is directed against the N-terminus, also failed to give any immunogold labelling, it would indicate that the truncated proteins are unstable. While non-speci®c cross-reacting bands were present in Western blots of all A-T and control samples they obviously did not lead to interference in the immunogold experiments. This might be explained by ecient removal of antibody from lower anity interactions under the conditions for preparation of ultrathin sections. As outlined above it is easy to accommodate a role for ATM in the nucleus but more dicult to rationalise the presence of this protein in vesicular structures in the cytoplasm. An attractive hypothesis is that the presence of ATM protein in the microsomes represents a specialised antioxidant system responsible for detoxifying reactive oxygen intermediates. Clearly the absence or dysfunction of this protein in A-T cells would render them less capable of dealing with oxidative stress generally. There is considerable evidence to support a continuous state of oxidative stress in A-T cells including defective post-irradiation activation of the stress-activated protein kinase (SAPK) (Shafman et al., 1995) . A DNA-binding protein which translocates to the nucleus in response to ionising radiation exposure is constitutively present in that organelle in A-T cells (Singh and Lavin, 1990; Teale et al., 1992 Teale et al., , 1993 . NF-kB is constitutively active in A-T cells and induction is not observed in response to radiation damage (Jung et al., 1995) . An observation which appears to be related to deregulated NF-kB is the constitutive activation of the interferon-b induction pathway in A-T cells (Siddo-Atwal et al., 1996) . In addition cyclin B-dependent protein kinase is also constitutively present in the nucleus, a distribution observed in normal ®broblasts in response to ionising radiation exposure (Paules et al., 1995) . A more comprehensive argument for supporting the hypothesis that A-T cells are defective in a more general cellular response to oxidative stress has been outlined recently . In summary we have produced polyclonal antibodies to the ATM protein and detected a protein of *350 kDa corresponding to the ORF which was not detected in 13/23 A-T cell lines. The ATM protein is present both in the nucleus and in cytoplasmic vesicles, consistent with a dual role in DNA-damage sensing and as a more general signal transduction intermediate.
Materials and methods
Cell lines and irradiation
Epstein ± Barr virus-transformed lymphoblastoid cells and primary ®broblasts were used in this study. Nomenclature for control and A-T lymphoblastoid cells is as described previously (Houldsworth and Lavin, 1980) . Control ®broblasts (NFF) were obtained from neonatal foreskin, A-T ®broblasts (AT4BI) were obtained from Colin Arlett (MRC Cell Mutation Unit, Falmer, UK) and the A-T lymphoblastoid cell line L3 was obtained from Yossi Shiloh (Sackler School of Medicine, Tel Aviv University). L3 is a cell line established from a North African Jewish A-T patient with a C?T transition at nucleotide 103 of the ORF resulting in a stop codon at amino acid position 35 of the ATM protein. AT27RMO was prepared from lymphocytes isolated from a patient in Moscow. All cells were cultured in RPMI 1640 medium supplemented with 10% foetal calf serum (FCS) at 378C in a humi®ed atmosphere of 5% CO 2 . For possible eects on cellular distribution cells were irradiated at 2.8 Gy/min in a 137 Cs source over the range 5 ± 10 Gy which is based on previous observations with DNA binding proteins (Singh and Lavin, 1990) .
Preparation of antibodies to the ATM protein
Three peptides corresponding to dierent parts of the predicted amino acid sequence were synthesised at Chiron Mimotopes (Melbourne) and at the Queensland Institute of Medical Research. An N-terminal cysteine was added in each case to facilitate coupling to carrier proteins. The regions of the ATM protein were as follows:-ATM-1BA: amino acids 12 ± 31, ATM-2BA: amino acids 1398 ± 1416, ATM-3BA: amino acids 2581 ± 2599 and ATM-4BA: amino acids 2323 ± 2740.
The peptides were coupled to Keyhole Limpet Haemocyanin (KLH) using MBS (m-maleimidobenzoyl-N-hydroxy succinimide ester) according to Harlow and Lane (1988) . The conjugates were injected intramuscularly into rabbits 1 : 1 with Freund's adjuvant and sera were tested by ELISA. The peptides were also conjugated to BSA using the same method as described above and the BSA-peptide conjugates were then coupled to activated CH-Sepharose (Pharmacia) for preparation of anity resins. In addition, for ATM-4BA, recombinant protein which overlapped with the peptide (amino acids, 2581 ± 2599) was prepared as described below and coupled to activated CH-Sepharose for anity purification. Preimmune serum was puri®ed on Protein A Sepharose.
Preparation of recombinant protein for the C-terminal portion of ATM
The QIA express system (Qiagen) was used for the expression of recombinant ATM protein corresponding to Puri®cation of recombinant protein was performed according to the QIA express protocol for denaturing conditions. Puri®ed protein was dialysed against PBS/0.1% SDS followed by PBS/0.05% Triton X-100 and used to generate antibodies (ATM-4BA). It was also coupled to activated CH-Sepharose for anity puri®cation of the antibody.
ELISA (Enzyme-linked immunosorbent assay)
To determine the titre of the rabbit antisera, peptides (5 mg/ml) or recombinant protein (10 mg/ml) were coated onto PVC MicroELISA plates by incubation in 50 mM carbonate/bicarbonate buer, pH 9.5. The plates were then blocked with 5% skim milk powder in PBS. After three washes in PBS, serum dilutions in 0.5% skim milk in PBS were added, starting at 1 : 100 and diluted serially twofold. All the above incubations were overnight at 48C. Plates were washed ®ve times in PBS containing 0.02% Tween 20 and the secondary antibody (HRP-anti-rabbit Ig, Amersham) was added at a dilution of 1 : 3000 in 0.5% skim milk in PBS for 90 min at 378C. Plates were washed ®ve times in PBS-Tween 20 and then the substrate (2, 2-azinobis 3-ethylbenz thiazoline sulphonic acid, ABTS activated with H 2 O 2 ) added. Absorbance was read at 405 nm in a Titertek MicroELISA Reader after 30 min.
Western blotting
At least 100 mg of protein per lane was loaded on 4.2% SDS ± PAGE gels with an acrylamide:bisacrylamide ratio of 100 : 1. The separated proteins were transferred to nitrocellulose membranes at 100 V for 1 h at 48C in Towbins buer. Protein loading was assessed by staining of the membranes with Ponceau S. The membranes were blocked by incubation in 5% skim milk powder in PBS containing 0.05% Tween 20 for a minimum of 1 h, then rinsed in PBS-Tween. Antibodies were incubated overnight at 48C or at least 1 h at room temperature in blocking solution. The ATM-2BA antibody was used at a dilution of 1 : 100 while ATM-1BA, ATM-3BA and ATM-4BA were used at 1 : 1000. The membranes were then washed three times in PBS-Tween and incubated with anti-rabbit secondary antibody (1 : 8000, Sigma). The chemiluminescence method of detection was used with the Renaissance Kit purchased from Dupont.
Preparation of nuclear and microsomal fractions
200 ml of cells, (approx. 2610 8 ), were washed in PBS, resuspended in 2 ml of ice-cold homogenisation buer (25 mM HEPES, 0.25 M sucrose, 1 mM EGTA, 5 mM MgSO 4 , 50 mM NaF, 1 mM DTT, 1 mM leupeptin, 1 mM aprotinin, 1 mM benzamidine and 2 mM PMSF) and homogenised with 50 strokes in a Dounce Homogeniser. After centrifugation at 2000 g for 15 min, the supernatant was retained for preparation of the microsomal fraction and the nuclear pellet lysed in 200 ml of lysis buer (50 mM TrisHCl, 150 mM NaCl, 2 mM EGTA, 2 mM EDTA, 25 mM NaF, 25 mM b-glycerophosphate, 0.1 mM sodium vanadate, 0.1 mM PMSF, 5 mg/ml leupeptin, 1 mg/ml aprotinin, 0.2% Triton X-100, 0.3% NP-40). After incubation on ice for 30 min, the debris was removed by centrifugation at 14 000 g for 15 min yielding the nuclear extract. The original supernatant was centrifuged at 100 000 g for 1 h in a TLN 100 Rotor (Beckman). The pellet (microsomal fraction) was resuspended in 50 ml of SDS-loading buer and the supernatant (post-microsomal fraction) retained. The protein concentration of each extract was determined using the Bradford assay. To determine the purity of the dierent fractions we utilised DNA-PKcs as a nuclear marker (Finnie et al., 1996) and lactate dehydrogenase as a cytoplasmic marker (Stolzenbach, 1966) .
Immunogold electronmicroscopy
For ultrathin cryosectioning and immunogold labelling, cells were ®xed in 4% paraformaldehyde in cacodylate buer and cryoprotected by in®ltration with 1.8 M sucrose. After freezing in liquid nitrogen, 60 nm frozen sections were cut on a cryoultramicrotome and mounted on coated nickel grids. Sections were incubated with the anitypuri®ed ATM speci®c antibodies, followed by anti-rabbit immunoglobulin secondary antibody conjugated to gold particles (Jansen Pharmaceuticals, Sweden). Antibodies were used at the following dilutions: ATM-1BA 1 : 50; ATM-2BA 1 : 20; ATM-3BA 1 : 100; gold labelled antirabbit Ig 1 : 100. Sections were post®xed in 1% glutaraldehyde, stained and embedded in uranyl acetate/PVA according to published procedures (Tokuyasu, 1989) . Grids were examined with a JEOL 1200EX electron microscope.
Protein truncation test (PTT)
The PTT was used to identify mutations resulting in inframe stop codons in the ATM ORF (Roest et al., 1993) . Total RNA was isolated from lymphoblastoid cell lines using a single-step guanidinium phenol extraction (Trizol, Gibco BRL). cDNA was synthesised from the RNA using a modi®ed MMLV reverse transcriptase (SuperScript II, Gibco BRL) and random hexamers (Pharmacia). PCR primer pairs were designed to amplify eight overlapping fragments of the ATM ORF. Overlaps of approximately 300 bp were necessary to avoid missing truncations close to a fragment end. All forward primers incorporated a T7 promoter sequence and initiation of translation codon to facilitate transcription and translation of the PCR products. The PCR products (1.2 to 1.5 kb) were used directly in a coupled transcription/translation assay (TNT T7 Coupled Reticulocyte Lysate System, Promega) with [ 35 S]methionine incorpoaration. The TNT T7 kit was used according to the manufacturer's instructions except that reaction volumes were scaled down from 50 ml to 6 ml. The reaction products were denatured and electrophoresed on 12% SDS ± PAGE. Gels were ®xed, soaked in a fluorographic reagent (Amplify, Amersham), dried and subjected to autoradiography.
In vivo association of ATM with p53
Control and A-T lymphoblastoid cells were irradiated with 6 Gy of ionising radiation (2.8 Gy/min) and incubated for 1 h. Cells were lysed in lysis buer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM EGTA, 1 mM EDTA, 25 mM sodium¯uoride, 25 mM b-glycerophosphate, 0.1 mM PMSF, 5 mg/ml leupeptin, 1 mg/ml aprotinin, 0.2% Triton X-100, 0.3% NP40). After incubation on ice for 30 min, the debris was removed by centrifugation at 14 000 g for 15 min, yielding the total cell extract. Anti-p53 immunoprecipitations were peformed with Pab 1801 antibody (Novacastra) and protein G-Sepharose overnight at 48C. Resulting protein complexes were washed three times in lysis buer and run on 5% SDS ± PAGE with an acrylamide: bisacrylamide ratio of 100 : 1. The separated proteins were transferred to PVDF membranes (Dupont) at 100 V for 1 h at 48C in Towbins buer and blotted with ATM-3BA antibody as described under Western blotting.
Yeast two-hybrid assay
The protein interactions between ATM and p53 were analysed by the yeast two-hybrid method, essentially as per the`Matchmaker Two Hybrid Kit' from Clontech. The distal half of ATM cDNA (amino acids 1666 ± 3100) containing the PI3-Kinase domain was cloned in pGAD10 fused to the Gal-4 transactivation domain. The bait plasmid, pVA3, encoding murine p53 (amino acids 72 ± 390) fused to Gal-4 DNA binding domain in PGBT9, was supplied with the kit. Both these plasmids were cotransformed into the Y190 yeast strain and transformants were selected on the 7leu and 7trp media. Positive control and negative control plasmids supplied with the kit were also transformed at the same time. The colonies that appeared after 2 ± 3 days were assayed for b-galactosidase by ®lter assays. Multiple colonies were picked and grown individually in selection media for quantitative b-galactosidase activity analysis.
